Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation

To evaluate the implications of intravitreal bevacizumab on proangiogenic vascular endothelial growth factor (VEGF) with regard to the endogenous angiogenesis inhibitor endostatin in human choroidal neovascularisation (CNV) secondary to age-related macular degeneration. Retrospective review of an in...

Full description

Saved in:

Bibliographic Details
Published in:	British journal of ophthalmology Vol. 93; no. 2; p. 159
Main Authors:	Tatar, O, Shinoda, K, Kaiserling, E, Claes, C, Eckardt, C, Eckert, T, Pertile, G, Boeyden, V, Scharioth, G B, Yoeruek, E, Szurman, P, Bartz-Schmidt, K U, Grisanti, S
Format:	Journal Article
Language:	English
Published:	England 01-02-2009
Subjects:	Aged Aged, 80 and over Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Bevacizumab Choroidal Neovascularization - drug therapy Choroidal Neovascularization - metabolism Choroidal Neovascularization - pathology Choroidal Neovascularization - surgery Combined Modality Therapy E-Selectin - metabolism Endostatins - metabolism Eye Proteins - metabolism Female Humans Macular Degeneration - complications Male Middle Aged Retinal Pigment Epithelium - metabolism Retrospective Studies Vascular Endothelial Growth Factor A - antagonists & inhibitors Vascular Endothelial Growth Factor A - metabolism
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!